Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07131631) titled 'Secondary Mitral Regurgitation Treatment With MitraClip and Assessment by Cardiac Magnetic Resonance' on Aug. 6.

Study Type: Observational

Primary Sponsor: Minneapolis Heart Institute Foundation

Condition: Heart Failure and Reduced Ejection Fraction Functional Mitral Regurgitation

Intervention: Diagnostic Test: Cardiac MRI

Recruitment Status: Recruiting

Date of First Enrollment: March 3, 2022

Target Sample Size: 125

Countries of Recruitment: United States

To know more, visit https://clinicaltrials.gov/ct2/show/NCT07131631

Published by HT Digital Content Services with permission from Health Daily Digest....